Pharmacogenomics and therapeutic drug monitoring: The challenge in drug safety

International Journal of Integrative Biology

Volumn 4, Issue 2, 2008, Pages 62-66

  Islam, Samira Ibrahim ^a  

^a KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

Author keywords

Drug safety; Pharmacogenomics; Therapeutic drug monitoring

Indexed keywords

ACYLTRANSFERASE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIINFECTIVE AGENT; AZATHIOPRINE; CARBAMAZEPINE; CARDIOVASCULAR AGENT; CYCLOSPORIN; CYTOCHROME P450; GLUCURONOSYLTRANSFERASE; HYDRALAZINE; ISONIAZID; MERCAPTOPURINE; PROCAINAMIDE; RECOMBINANT DNA; SULFONAMIDE; THEOPHYLLINE; THIOPURINE METHYLTRANSFERASE; THYROID HORMONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; AGE; AUTOIMMUNE DISEASE; BLOOD SAMPLING; BODY WEIGHT; DISTRIBUTION VOLUME; DRUG CLEARANCE; DRUG EFFICACY; DRUG HALF LIFE; DRUG METABOLISM; DRUG MONITORING; DRUG SAFETY; DRUG USE; ENTERITIS; GENDER; GENE FUNCTION; GENE SEQUENCE; GENE TECHNOLOGY; HUMAN; HUMAN GENOME; PHARMACOGENOMICS; PRACTICE GUIDELINE; REVIEW; SKIN MANIFESTATION; STEVENS JOHNSON SYNDROME; TOXIC EPIDERMAL NECROLYSIS;

EID: 64549084621     PISSN: 09738363     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (22)

1. Abrahams R et al. (2005) The personalized medicine coalition goals and strategies. Am J Pharmacogenomics 5: 345-355.
2. Alfirevic A et al. (2006 HLA-B locus in Caucasian patients with carbamazepine hypersensitivity. Pharmacogenomics 7(6):813-818
3. Bowers LD (2008) Analytical goals in therapeutic drug monitoring. Clim. Chem. 44(2):375-383.
4. Children's Medical Centre (1995) An overview of Therapeutic Drug Monitoring: Why, When and How. Paediatric Pharmacotheraphy 1(7).
5. El-Sayed YM, Islam SI (1989) Acetylation Phenotyping Od Isoniazid Using A Simple And Accurate High-Performance Liquid Chromatography. Journal of Clinical Pharmacy and Therapeutics 44: 197-205
6. FDA (2008 Pharmacogenomics an its role in drug safety. FDA Drug Safety Newsletter.
7. GRACE 2008. The issues: Genetic Engineering. Sustainable Table http://www.sustainabletable.org
8. Islam SI (1982) Polymorphic Acetylation Of Sulphamethazine In Rural Bedouin And Urban Dwellers In Saudi Arabia. Xenobiotica 12(5): 323-328
9. Islam SI, Idle JR and Smith RL (1980) The Polymorphic 4-Hydroxylation Of Debrisoquine. In A Saudi Arab Population Xenobiotica 10(11): 819-825
10. Islam SI (1994) Application of Pharmacokinetic Principle in Therapeutic Drug Monitoring. Presented in the 12th Educational & Training Programme on Toxicology, Drug Information & Frorensic Chemistry, Ministry of Health, Jeddah, Saudi Arabia
11. Kuzma J (2005) Global Challenges and Biotechnology. Economic Perspective. eJournal USA
12. Lefebra HP (2007) Therapeutic Drug Monitoring http://www.vin.com/
13. Lab Tests Online (2006) Therapeutic Drug Monitoring http://www.labtestsonline.org/
14. Lab Tests Online. Pharmacogenomics http://www.labtestsonline.org Therapeutic Drug Monitoring 2006. Essential Guide to Prescription Drug http://www.drugwww.com/
15. Lazarou J et al. (1998) Incidence of adverse drug reactions in hospitalized patients: a meta-analysis of prospective studies. JAMA: 279(15):1200-1205
16. McLeod HL (2007) Personalized Drug Therapy: The Era of Pharmacogenomics http://www.gastro.org/
17. Mura SA, et al. (1985) Therapeutic Drug Monitoring Concept, analytical mothodology and clinical application. South Medical Journal 6:581-591
18. Pirmohamed M, James S et al. (2004) Adverse drug reaction as cause of admission to hospital: prospective analysis of 18820 patients. BMJ 239(7456:15-19
19. National Health Policy Forum 2008 http://www.nhpf.org./
20. Snyder B (2005) the transforming power of Biotechnology. eJournal USA http://usinfo.state.gov
21. Therapeutic drug levels http://www.umm.edu/
22. Tayeb OS, Al-Fares AM. El-Sayed YM and Islam SI (1988) Correlation Between Predicted And Measured Digoxin Serum Concentrations. Journal of Clinical Pharmacy and Therapeutics 13:159-163.